Streetbeat News

Stock Prices

GME

GameStop Corporation (NYSE:GME) shares are trading higher on above-average volume ahead of its Q2 financial results announcement. The company is expected to report a loss of 14 cents per share and revenue of $1.14 billion. Short-sellers continue to target GameStop with 19.12% of available shares being sold short.

Portfolio Pulse from Erica Kollmann

September 05, 2023 | 6:03 pm

IREN

In the last quarter, Iris Energy (NASDAQ:IREN) received 2 bullish and 3 somewhat bullish ratings from analysts. The company's average 12-month price target has increased by 12.5% from $8.00 to $9.00.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:01 pm

UNH

A significant bullish stance has been taken on UnitedHealth Group (NYSE:UNH) as indicated by unusual options activity. The sentiment among these big-money traders is split between 52% bullish and 47% bearish. The whales have been targeting a price range from $230.0 to $670.0 for UnitedHealth Group over the last 3 months. The price of UNH is up 1.66% at $484.15. Stephens & Co. downgraded its action to Overweight with a price target of $560.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

RSI

Rush Street Interactive (NYSE:RSI) has received 4 analyst ratings in the last quarter, with 1 being bullish and 3 somewhat bullish. The company has an average 12-month price target of $6.25, which has increased by 31.58% over the past month.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

CVE

Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years, producing an average annual return of 17.5%. If an investor had bought $1000 of CVE stock 5 years ago, it would be worth $2,270.83 today.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

GMED

Globus Medical (NYSE:GMED) has received one somewhat bullish and four indifferent analyst ratings in the last quarter. The average price target is $67.6, indicating an upside from the current price of $54.085. The average price target has increased by 0.9% over the past month.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

WIT

Wipro (NYSE:WIT) has outperformed the market over the past 20 years, producing an average annual return of 9.02%. If an investor had bought $1000 of WIT stock 20 years ago, it would be worth $5,428.55 today. The company currently has a market capitalization of $26.89 billion.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

WEN

Analysts have provided various ratings for Wendy's (NASDAQ:WEN) within the last quarter, with 1 bullish, 6 somewhat bullish, and 6 indifferent. The average price target is $24.85, representing an upside from the current price of $20.125. This average is a 5.33% decrease from the previous average price target of $26.25.

Portfolio Pulse from Benzinga Insights

September 05, 2023 | 6:00 pm

SNOW

Needham analyst Mike Cikos reiterated a Buy rating on Snowflake Inc (NYSE:SNOW) with a price target of $216. The analyst believes Snowflake's expansion and its Cloud-Native Data Platform are disrupting the market and making it a strong competitor against Databricks. The company is expected to see FY24 revenues rise 32.5% Y/Y to $2.737 billion and FY25 revenues of $3.415 billion, up 24.7% Y/Y.

Portfolio Pulse from Nabaparna Bhattacharya

September 05, 2023 | 5:59 pm

BEAM

Beam Therapeutics Inc has announced that the first patient was treated with BEAM-201, a quadruplex-edited allogeneic CAR-T cell investigational therapy, marking a significant milestone for the company and the gene editing sector. Analysts from William Blair maintain an Outperform rating for Beam Therapeutics, considering the company to be at the forefront of the next wave of gene-editing companies. Beam's shares are down 0.38% at $23.37 on the last check Tuesday.

Portfolio Pulse from Vandana Singh

September 05, 2023 | 5:58 pm